Join us for the FA Research Flash Talk Series

This year, in honor of FA Awareness month, FARA is proud to present: The FA Research Flash Talks series - featuring Young Investigators from FARA funded laboratories around the world. This four-part series will cover key aspects of FARA funded research from gene silencing and disease mechanisms to therapeutic avenues and clinical insights. Each session will include Flash Talks from four to five Young Investigators (ie, postdocs and graduate students). Each Flash Talk will be limited to a maximum of five minutes and a single PowerPoint slide and will be suitable for a lay audience. We will also allott time for a brief Q&A following the talks. Click the button below to register for one, two, three, or all four of the sessions. You will have the option to select which sessions you wish to attend.

Register for the Sessions

Session #1 May 6, 2021 - 7pm EDT

Investigating epigenetic silencing in Friedreich's Ataxia Rucha Dilip Sarwade, Monash University Antisense oligonucleotides targeting FXN intron 1 can activate FXN expression Feng Damon Wang, UMass Medical School NAD+ and Exercise in Friedreich's Ataxia Jaclyn Tamaroff, Children's Hospital of Philadelphia Brain white matter pathways in FA Louisa Selvadurai, Monash University

Session #2 May 13, 2021 - 12pm EDT

Visceral white adipose tissue as a possible therapeutic target to prevent type 2 diabetes development in Friedreich’s ataxia Riccardo Turchi, University of Tor vergata, Rome An in vitro Model System for the Study of Proprioceptor Vulnerability in Friedreich's Ataxia Chiara Dionisi, Université Libre de Bruxelles Transplantation of CRISPR/Cas9 Corrected Hematopoietic Stem and Progenitor Cells into a Mouse Model of Friedreich's Ataxia Joseph N Rainaldi, University of California, San Diego White Matter Damage Staging Schema in Friedreich Ataxia Thiago JR Rezende, University of Campinas IDEA Study: Searching For a Better Way to Measure Ataxia Hannah Casey, The University of Chicago

Session #3 May 20, 2021 - 7pm EDT

Molecular defects in Friedreich's Ataxia - pathophysiological cytoskeletal abnormalities Frances M Smith, University at Buffalo Friedreich's ataxia neuronal progenitor cells (NPCs) containing an endogenous FXN-luciferase fusion gene as a novel screening platform Anna Maria Schreiber, University of Alabama at Birmingham Sugar-based nanoparticles for frataxin delivery Ewa Czuba-Wojnilowicz, The University of Melbourne Spinal cord diffusion tensor imaging in Friedreich’s ataxia Ana Luisa de Carvalho Cardozo Hernández, University of Campinas Bone Health in Friedreich's Ataxia Julia Dunn, Children's Hospital of Philadelphia

Session #4 May 27, 2021 - 12pm EDT

Cytoskeletal filament proteins in Friedreich cardiomyopathy Rahman F Rafique, Albany Research Institute Application of genome editing technologies in potential therapeutics of Friedreich ataxia Zaneta Matuszek, Harvard University/the Broad Institute Pre-clinical left ventricular myocardial remodeling in patients with Friedreich’s ataxia: A cardiac MRI study Karen Girotto, University of Campinas The Friedreich's ataxia Health Indices (FA-HI): Novel Outcomes for Measuring How a Patient Feels and Functions in Clinical Trials Jamison Seabury, University of Rochester Center for Health + Technology

‌ ‌ ‌